↓ Skip to main content

Dove Medical Press

Article Metrics

A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients

Overview of attention for article published in Drug Design, Development and Therapy, November 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

patent
7 patents

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
44 Mendeley